You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jul 18, 2025

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
Published on: May 16, 2021
1Department of Cancer Biology, Chemical Biology Program, Dana-Farber Cancer Institute; milka_kostic@dfci.harvard.edu.
This study reviews various high-throughput screening assays for drug discovery. It highlights methods for identifying kinase inhibitors, assessing chemical toxicity, and validating drug-protein interactions for therapeutic development.
Area of Science:
Background:
08:43A Fluorescence-based Lymphocyte Assay Suitable for High-throughput Screening of Small Molecules
Published on: March 10, 2017
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020